PepVax

PepVax, Inc. has developed a novel DNA-based drug delivery and development platform, called SMARTmid™, to make safer and more effective treatments inside the patient (Intusic™) using a “Trojan Horse” approach. The company is currently focusing on treatment efforts for COVID-19.